Volume | 0 |
|
|||||
News | - |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
GeoVax Labs Inc | GOVXW | NASDAQ | Equity Warrant |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
0.0364 | 0.0364 |
Trades | Shares Traded | Average Volume |
---|---|---|
0 | 0 | - |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
- | 0 | 0.0364 | USD |
GeoVax Labs Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
31.5M | 26.70M | - | 0 | -25.97M | -0.97 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
News GeoVax Labs
Date | Time | Source | Heading |
---|---|---|---|
6/07/2024 | 15:01 | Edgar (US Regulatory) | Form S-1 - General form for registration of securities under.. |
5/24/2024 | 15:04 | Edgar (US Regulatory) | Form 8-K - Current report |
5/23/2024 | 15:07 | Edgar (US Regulatory) | Form 8-K - Current report |
5/21/2024 | 16:23 | Edgar (US Regulatory) | Form 8-K - Current report |
5/21/2024 | 11:32 | Edgar (US Regulatory) | Form 424B5 - Prospectus [Rule 424(b)(5)] |
5/15/2024 | 15:03 | Edgar (US Regulatory) | Form 8-K - Current report |
5/14/2024 | 16:09 | Edgar (US Regulatory) | Form 424B3 - Prospectus [Rule 424(b)(3)] |
5/14/2024 | 16:09 | Edgar (US Regulatory) | Form 424B3 - Prospectus [Rule 424(b)(3)] |
5/14/2024 | 16:08 | Edgar (US Regulatory) | Form 424B3 - Prospectus [Rule 424(b)(3)] |
5/14/2024 | 16:07 | Edgar (US Regulatory) | Form 424B3 - Prospectus [Rule 424(b)(3)] |
5/14/2024 | 15:01 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
4/04/2024 | 11:30 | GlobeNewswire Inc. | GeoVax Presents Data on GEO-CM04S1, a Next Generation.. |
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
GOVXW Historical
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
1 Month | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
3 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
6 Months | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
1 Year | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
3 Years | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
5 Years | 0.00 | 0.00 | 0.00 | 0.00 | 0 | 0.00 | 0.00% |
Geovax Labs Inc is us-based clinical-stage biotechnology company. |